Immediate Impact
1 from Science/Nature 35 standout
Citing Papers
Potential Clinical and Economic Impacts of Cutbacks in the President’s Emergency Plan for AIDS Relief Program in South Africa
2025 Standout
Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial
2024 Standout
Works of Kim Steegen being referenced
Dolutegravir Resistance in Malawi’s National HIV Treatment Program
2022
Intensive adherence counselling for HIV‐infected individuals failing second‐line antiretroviral therapy in Johannesburg, South Africa
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kim Steegen | 660 | 584 | 59 | 110 | 43 | 707 | |
| Isabelle Charreau | 440 | 331 | 42 | 193 | 36 | 632 | |
| Mariëtte E. Botes | 734 | 620 | 23 | 175 | 14 | 805 | |
| Shujia Liang | 506 | 458 | 34 | 201 | 67 | 608 | |
| Jean Ruelle | 517 | 435 | 110 | 172 | 42 | 709 | |
| Donald J. Hamel | 593 | 537 | 48 | 124 | 24 | 719 | |
| Deogratius Ssemwanga | 558 | 547 | 137 | 209 | 45 | 757 | |
| Karidia Diallo | 609 | 497 | 63 | 160 | 44 | 721 | |
| Sarah E. Hudelson | 525 | 433 | 33 | 149 | 25 | 576 | |
| Angela Holder | 526 | 379 | 87 | 204 | 37 | 694 | |
| Halimatou Diop‐Ndiaye | 472 | 381 | 51 | 281 | 64 | 704 |
All Works
Login with ORCID to disown or claim papers
Loading papers...